A survey of 374 clinicians shows how weight-loss drug demand is changing daily practice.

Weight-loss drugs have moved from a niche prescribing category into a daily reality for most healthcare providers. Tebra surveyed 374 clinicians who prescribe or manage patients on GLP-1 medications, and the results show how deeply that demand is reaching into daily practice.

The data covers how providers spend their time, how burned out they feel, and whether the shift toward oral GLP-1 pills is likely to ease that load or add to it.

For many providers, the biggest cost of the GLP-1 boom shows up as time spent on administrative work.

For many providers, the strain hits closer to home than scheduling and paperwork.

Here's where that toll shows up:

A new form factor is entering the picture, and some providers expect it to add to their workload rather than lighten it. Retail pharmacies and telehealth platforms are increasingly lowering the barrier to starting a GLP-1, from cash-pay virtual visits to in-app access to newer oral formulations. That ease of access on the front end doesn't extend to what comes after. Monitoring, refills, and side-effect management still fall to the practices managing these patients well past their first visit.

Here's how providers see the pill shift playing out:

GLP-1 demand keeps climbing, and for many private practices, the workload behind it is climbing right along with it. Providers are absorbing extra hours, correcting misinformation, and adjusting to new drug formats largely on their own time. How a practice chooses to redistribute that load, whether through staffing, workflow changes, or new electronic prescribing and patient experience tools, may matter as much to patient care as the medications themselves.

Tebra surveyed 374 healthcare providers who currently prescribe or manage patients on GLP-1 medications in July 2026. Respondents included physicians, nurse practitioners, physician assistants, registered nurses, licensed practical nurses, pharmacists, and other licensed clinical providers. 

For questions that allowed multiple responses, percentages are based on the total number of respondents who answered that question, so figures may add up to more than 100%. All percentages are rounded to the nearest whole number and may not sum to exactly 100% due to rounding.

Tebra, headquartered in Southern California, empowers private healthcare practices with AI and automation to drive growth, streamline care, and boost efficiency. Our all-in-one EHR and billing platform delivers everything you need to attract and engage your patients, including online scheduling, reputation management, and digital communications.

This research is available for noncommercial reuse with proper attribution and a link back to this page. For media inquiries or questions about the data, please reach out to Tebra directly.